The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
In vivo suppression of early experimental osteoarthritis by interleukin‐1 receptor antagonist using gene therapy
Abstract
Objective. This study explored the therapeutic effect of interleukin‐1 receptor antagonist (IL‐1Ra), administered by gene transfer, on the progression of osteoarthritic (OA) lesions in an experimental dog model. Methods. Seventeen mature mongrel dogs were divided into 3 groups. Group 1 (n = 7) had an anterior cruciate ligament (ACL) section of the right knee through a stab wound incision. Groups 2 and 3 (n = 5 per group), had an ACL section of the right knee and partial synovectomy of the left knee. Each dog's synovium was subjected to enzymatic digestion, and the synovial fibroblasts were propagated in monolayer culture. Synovial cells from each dog were transduced in vitro using the retrovirus MFG with either the Escherichia coli β‐galactosidase (lac Z) gene (group 2) or the human IL‐1Ra gene (group 3). Two days after surgery, the dogs received intraarticular injections as follows: group 1 phosphate buffered saline (PBS) (2 ml); group 2 autologous cells (60 × 10 6 cells/2 ml of PBS) transduced with the lac Z gene; group 3 autologous cells transduced with the IL‐1Ra gene. Synovial fluid was aspirated at 2 weeks and 4 weeks. All dogs were euthanized at 4 weeks postsurgery. The right knees were dissected, and lesions were scored for macroscopic and microscopic changes. Synovial explants were dissected and representative specimens were used for histology or were cultured for 48 hours. The levels of IL‐1Ra in synovial fluid and synovial explant conditioned medium were measured by specific enzyme‐linked immunosorbent assay. Results. The level of IL‐1Ra in synovial fluid of group 3 was 202.8 ± 131.5 ng/ml (mean ± SEM) at 2 weeks and 2.8 ± 2.2 ng/ml at 4 weeks after surgery. Membrane explants isolated from dogs that received synovial cells transduced with the IL‐1Ra gene (group 3) actively produced IL‐1Ra (4.0 ± 2.0 ng/gm of tissue wet weight). The severity of OA cartilage lesions was similar in groups 1 and 2. In contrast, group 3 dogs had a marked reduction in macroscopic lesion severity on the tibial plateaus (P < 0.01 for grade; P < 0.04 for size) and femoral condyles. Moreover, the histologic lesion severity was decreased on both plateaus (P < 0.06) and condyles. Conclusion. This study showed that a local increase in IL‐1Ra production in OA knee joints by intraarticular injection of transduced synovial cells can reduce the progression of experimentally induced lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANKIN, H. J., DORFMAN, H., LIPPIELLO, L., & ZARINS, A. (1971) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-197153030-00009 · Cited by 1,963
Charalambous, C. P. (2014) · Classic Papers in Orthopaedics · doi:10.1007/978-1-4471-5451-8_97 · Cited by 1,835
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Tripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Palmer, T. D., Rosman, G. J., Osborne, W. R., & Miller, A. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1330 · Cited by 479
Caron, J. P., Fernandes, J. C., Martel‐Pelletier, J., Tardif, G., Mineau, F., Geng, C., & Pelletier, J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390914 · Cited by 366
Self-citationArthritis and Allied Conditions: A Textbook of Rheumatology
Smyth, C. J. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03360180182053 · Cited by 322
Bandara, G., Mueller, G. M., Galea-Lauri, J., Tindal, M. H., Georgescu, H. I., Suchanek, M. K., Hung, G. L., Glorioso, J. C., Robbins, P. D., & Evans, C. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10764 · Cited by 290
Self-citationEvans, C. H., Mankin, H. J., Robbins, P. D., Ghivizzani, S. C., Herndon, J. H., Kang, R., Bahnson, A. B., Barranger, J. A., Elders, E. M., Gay, S., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.10-1261 · Cited by 252
Self-citation
Cited by
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
Self-citationINTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Pelletier, J.-P., Martel-Pelletier, J., & Abramson, S. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1237::aid-art214>3.0.co;2-f · Cited by 1,072
Self-citationThe balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis
Goldring, S. R., & Goldring, M. B. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000144854.66565.8f · Cited by 654
Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E. (2009) · Arthritis Care & Research · doi:10.1002/art.24096 · Cited by 533
Osteoarthritis and cartilage: The role of cytokines
Goldring, M. B. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-000-0021-y · Cited by 452
Immunopathogenesis of osteoarthritis
Haseeb, A., & Haqqi, T. M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2012.12.011 · Cited by 416
The role of nitric oxide in inflammation and immunity
Clancy, R. M., Amin, A. R., & Abramson, S. B. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1141::aid-art2>3.0.co;2-s · Cited by 409
Frisbie, D., Ghivizzani, S., Robbins, P., Evans, C., & McIlwraith, C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301608 · Cited by 385
Self-citationMoore, E. E., Bendele, A. M., Thompson, D. L., Littau, A., Waggie, K. S., Reardon, B., & Ellsworth, J. L. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.03.003 · Cited by 368
Nishida, K., Kang, J. D., Gilbertson, L. G., Moon, S.-H., Suh, J.-K., Vogt, M. T., Robbins, P. D., & Evans, C. H. (1999) · Spine · doi:10.1097/00007632-199912010-00002 · Cited by 347
Self-citationMajor biological obstacles for persistent cell-based regeneration of articular cartilage
Steinert, A. F., Ghivizzani, S. C., Rethwilm, A., Tuan, R. S., Evans, C. H., & Nöth, U. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2195 · Cited by 321
Self-citationAutologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis
Baltzer, A. W. A., Moser, C., Jansen, S. A., & Krauspe, R. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.06.014 · Cited by 317
Sacitharan, P. K. (2019) · Subcellular Biochemistry · doi:10.1007/978-981-13-3681-2_6 · Cited by 308
Hardy, M. M., Seibert, K., Manning, P. T., Currie, M. G., Woerner, B. M., Edwards, D., Koki, A., & Tripp, C. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10356 · Cited by 302
Lotz, M. K. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3046 · Cited by 294
Ghivizzani, S. C., Lechman, E. R., Kang, R., Tio, C., Kolls, J., Evans, C. H., & Robbins, P. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4613 · Cited by 287
Self-citationThe Role of Cytokines as Inflammatory Mediators in Osteoarthritis: Lessons from Animal Models
Goldring, M. B. (1999) · Connective Tissue Research · doi:10.3109/03008209909005273 · Cited by 283
Interleukin-1 function and role in rheumatic disease
Schett, G., Dayer, J.-M., & Manger, B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.166 · Cited by 279
Martin, I., Vunjak-Novakovic, G., Yang, J., Langer, R., & Freed, L. E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4708 · Cited by 261
Melchiorri, C., Meliconi, R., Frizziero, L., Silvestri, T., Pulsatelli, L., Mazzetti, I., Borz�, R. M., Uguccioni, M., & Facchini, A. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2165::aid-art11>3.0.co;2-o · Cited by 253
Cytokines and their role in the pathophysiology of osteoarthritis
Martel-Pelletier, J. (1999) · Frontiers in Bioscience · doi:10.2741/a387 · Cited by 253
Self-citationBlocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Cell delivery therapeutics for musculoskeletal regeneration☆
Nöth, U., Rackwitz, L., Steinert, A. F., & Tuan, R. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.004 · Cited by 119
Metadata
- Authors
- Pelletier, J., Caron, J. P., Evans, C., Robbins, P. D., Georgescu, H. I., Jovanovic, D., Fernandes, J. C., & Martel‐Pelletier, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-06
- Volume
- 40
- Issue
- 6
- Pages
- 1012-1019
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2024452130
- Cited by
- 378
- References
- 27
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.